Coronary Artery Disease
📧 Sign up to get email alerts when something new happens for Coronary Artery Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial [Phase 4]
A Phase 4 randomized trial (ENIGMA II) evaluated whether nitrous oxide anesthesia influences cardiac morbidity after major surgery in patien…
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: Increasing Cardiac Rehabilitation Participation Among Medicaid Enrollees [NA]
Completed clinical trial evaluating strategies to increase participation in cardiac rehabilitation among Medicaid enrollees with coronary ar…
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: Sedentary Intervention Trial in Cardiac Rehabilitation [NA]
Completed clinical trial evaluating sedentary intervention in cardiac rehabilitation for coronary artery disease; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: Glutamate for Metabolic Intervention in Coronary Surgery [Phase 3]
Phase 3 trial evaluating glutamate for metabolic intervention in patients undergoing coronary surgery has completed and results have been po…
-
CLINICAL_TRIALS trial_result · 2019-06-07Clinical Trial Update: ROOBY Trial Follow-up Extension
Follow-up extension update for the ROOBY trial; results completed and posted in 2019, focusing on all-cause mortality and major adverse card…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2019-05-31Clinical Trial Update: Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis [Phase 4]
Phase 4 clinical trial evaluating the use of CCTA and MRI to detect unrecognized myocardial scar in asymptomatic patients with type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control [Phase 4]
A Phase 4 clinical trial evaluated magnesium's effect on blood pressure, cholesterol, and glucose control in patients with cardiovascular ri…
-
CLINICAL_TRIALS trial_result · 2019-05-17Clinical Trial Update: Anticoagulant Treatments and Percutaneous Coronary Angioplasty [Phase 4]
Phase 4 clinical trial update on anticoagulant treatments in patients undergoing percutaneous coronary angioplasty.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone [Phase 4]
Phase 4 clinical trial update comparing combined statin plus fenofibrate therapy versus statin alone for effects on coronary atherosclerotic…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure [Phase 3]
Phase 3 trial evaluating rivaroxaban to reduce death, myocardial infarction, or stroke in heart failure patients with coronary artery diseas…
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: PLATINUM Diversity
A completed clinical trial related to atherosclerosis and coronary artery disease has results posted.
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Allogeneic Stem Cells Implantation Combined With Coronary Bypass Grafting in Patients With Ischemic Cardiomyopathy [Phase 2]
A Phase 2 trial evaluating allogeneic stem cell implantation combined with coronary bypass grafting in patients with ischemic cardiomyopathy…
-
CLINICAL_TRIALS trial_result · 2019-05-07Clinical Trial Update: Prophylactic Administration of Levosimendan in Patients Undergoing Coronary Surgery [Phase 4]
Phase 4 trial update on prophylactic use of levosimendan in patients undergoing coronary surgery.
-
FDA approval · 2019-04-30FDA Approved: NITROGLYCERIN — Original Application (Natco Pharma USA LLC)
FDA has approved Natco Pharma USA LLC's Nitroglycerin generic under an Original Application (ANDA211604).
-
CLINICAL_TRIALS withdrawal · 2019-04-29Clinical Trial Update: Renal Effects of Three Iodinated Contrast Media (CM) in Patients at Risk Undergoing Coronary Angiography [Phase 4]
A Phase 4 trial evaluating renal effects of three iodinated contrast media in patients at risk undergoing coronary angiography has been with…
-
FDA approval · 2019-04-26FDA Approved: CARDIOGEN-82 — Supplemental Application (Bracco Diagnostics Inc)
The FDA approved a supplemental application for CardioGen-82 (rubidium-82 chloride) submitted by Bracco Diagnostics Inc.
-
FDA approval · 2019-04-26FDA Approved: RUBY-FILL — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for RUBY-FILL (rubidium-82) from Jubilant Radiopharma, expanding its approved use related to PET myo…
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart [Phase 3]
Phase 3 trial update on safety and effectiveness of Visipaque 320 mg-I/mL for contrast-enhanced CT angiography of coronary arteries, termina…
-
CLINICAL_TRIALS trial_result · 2019-04-25Clinical Trial Update: Safety and Effectiveness of Visipaque 320mg-I/ml for Use in Contrast-Enhanced CT Angiography of Arteries of the Heart [Phase 3]
Phase 3 trial update on safety and effectiveness of Visipaque 320 mg/mL for contrast-enhanced CT angiography of coronary arteries.
-
CLINICAL_TRIALS trial_result · 2019-04-24Clinical Trial Update: Multi-center Prospective Study to Evaluate Outcomes of the Moderate to Severely Calcified Coronary Lesions (MACE)
A multi-center prospective trial evaluating outcomes in patients with moderate to severely calcified coronary lesions has completed, with re…
-
CLINICAL_TRIALS trial_result · 2019-04-10Clinical Trial Update: MetfoRmin and Its Effects on Left Ventricular Hypertrophy in Normotensive Patients With Coronary Artery Disease [Phase 4]
Phase 4 trial evaluating MetfoRmin and its effects on left ventricular hypertrophy in normotensive patients with coronary artery disease; st…
-
FDA approval · 2019-04-02FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine [Phase 4]
A Phase 4 clinical trial evaluating how naloxone affects the pharmacokinetics and pharmacodynamics of ticagrelor in patients with unstable a…
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study
A completed single-arm study in China evaluated the XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) with posted results in 201…
-
FDA approval · 2019-03-28FDA Approved: EFFIENT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for EFFIENT (prasugrel hydrochloride) from Cosette Pharmaceuticals, Inc., indicating updates to the …